FTH
Faeth Therapeutics, Inc.
Company overview
- Market capitalization
- $717.59M
- Employees
- 29
- Latest publication
- 2026-09-29
About Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | -4,851,000USD | 0USD | 0USD |
| Cost Of Revenue | 132,957,000USD | — | -4,851,000USD | — | — |
| Gross Profit | -132,957,000USD | — | — | — | — |
| Research Development | 17,957,000USD | 2,166,000USD | 2,536,000USD | 2,533,000USD | 3,725,000USD |
| Selling General Administrative | 19,713,000USD | 2,791,000USD | 2,315,000USD | 2,673,000USD | 3,549,000USD |
| Total Operating Expenses | 37,670,000USD | 4,957,000USD | 4,851,000USD | 5,206,000USD | 7,274,000USD |
| Operating Income | -170,627,000USD | -4,957,000USD | -4,851,000USD | -5,206,000USD | -7,274,000USD |
| Interest Income | 392,000USD | 223,000USD | 289,000USD | 321,000USD | 392,000USD |
| Net Interest Income | 392,000USD | 220,000USD | 283,000USD | 311,000USD | 392,000USD |
| Income Before Tax | -170,236,000USD | -4,717,000USD | -4,569,000USD | -4,936,000USD | -6,864,000USD |
| Net Income | -170,236,000USD | -4,717,000USD | -4,569,000USD | -4,936,000USD | -6,864,000USD |
| Net Income From Continuing Ops | -170,236,000USD | -4,717,000USD | -4,569,000USD | -4,936,000USD | -6,864,000USD |
| Ebit | -170,236,000USD | -4,714,000USD | -4,563,000USD | -4,926,000USD | — |
| Ebitda | -170,206,000USD | -4,680,000USD | -4,529,000USD | -4,889,000USD | — |
| Depreciation And Amortization | 30,000USD | 34,000USD | 34,000USD | 37,000USD | — |
| Reconciled Depreciation | 30,000USD | 34,000USD | 34,000USD | 37,000USD | 34,000USD |
| Total Other Income Expense Net | 391,000USD | 240,000USD | 282,000USD | 270,000USD | 18,000USD |
| Interest Expense | — | 3,000USD | 6,000USD | 10,000USD | 13,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD |
| Research Development | 10,960,000USD | 18,627,000USD | 18,299,000USD | 29,583,000USD |
| Selling General Administrative | 11,328,000USD | 13,036,000USD | 18,665,000USD | 19,805,000USD |
| Total Operating Expenses | 22,288,000USD | 31,112,000USD | 36,493,000USD | 47,312,000USD |
| Operating Income | -22,288,000USD | -31,663,000USD | -37,064,000USD | -49,120,000USD |
| Interest Income | 1,239,000USD | 2,550,000USD | 3,624,000USD | 1,783,000USD |
| Interest Expense | 32,000USD | 90,000USD | 144,000USD | 219,000USD |
| Net Interest Income | 1,207,000USD | 2,460,000USD | 3,480,000USD | 1,564,000USD |
| Income Before Tax | -21,085,000USD | -30,157,000USD | -34,101,000USD | -48,588,000USD |
| Net Income | -21,085,000USD | -30,157,000USD | -34,101,000USD | -48,588,000USD |
| Net Income From Continuing Ops | -21,085,000USD | -30,157,000USD | -34,101,000USD | -48,588,000USD |
| Ebit | -21,053,000USD | -30,067,000USD | -37,064,000USD | -48,369,000USD |
| Ebitda | -20,914,000USD | -29,516,000USD | -33,386,000USD | -46,561,000USD |
| Depreciation And Amortization | 139,000USD | 551,000USD | 3,678,000USD | 1,808,000USD |
| Reconciled Depreciation | 139,000USD | 1,322,000USD | 1,351,000USD | 1,347,000USD |
| Total Other Income Expense Net | 1,203,000USD | 1,506,000USD | 2,963,000USD | 532,000USD |
| Cost Of Revenue | — | 551,000USD | 571,000USD | 1,808,000USD |
| Gross Profit | — | -551,000USD | -571,000USD | -1,808,000USD |
| Selling And Marketing Expenses | — | — | 100,000USD | — |
| Unclassified Operating Expenses | — | — | — | -2,076,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 189,306,000USD | 205,381,000USD | 22,902,000USD | 27,589,000USD | 31,783,000USD | 38,273,000USD |
| Cash And Equivalents | 26,903,000USD | — | — | — | — | — |
| Total Current Assets | 188,658,000USD | 204,232,000USD | 21,507,000USD | 25,785,000USD | 29,572,000USD | 35,682,000USD |
| Other Current Assets | 858,000USD | 1,439,000USD | 323,000USD | 744,000USD | 944,000USD | 440,000USD |
| Other Non Current Assets | 80,000USD | — | — | — | — | — |
| Total Liabilities | 9,581,000USD | — | — | — | — | — |
| Total Current Liabilities | 9,580,000USD | 14,190,000USD | 4,251,000USD | 4,436,000USD | 3,873,000USD | 5,229,000USD |
| Other Non Current Liabilities | 1,000USD | — | — | — | — | — |
| Total Stockholder Equity | 172,958,000USD | 191,190,000USD | 18,592,000USD | 23,007,000USD | 27,314,000USD | 31,987,000USD |
| Total Equity Including Noncontrolling Interest | 179,725,000USD | — | — | — | — | — |
| Property Plant Equipment Net | 568,000USD | 982,000USD | 1,377,000USD | 1,786,000USD | 2,187,000USD | 2,567,000USD |
| Accounts Payable | 7,573,000USD | 3,418,000USD | 689,000USD | 306,000USD | 351,000USD | 361,000USD |
| Short Term Debt | 592,000USD | 1,039,000USD | 1,450,000USD | 1,875,000USD | 1,963,000USD | — |
| Common Stock | 2,000USD | — | — | — | — | — |
| Retained Earnings | -469,400,000USD | -453,373,000USD | -283,137,000USD | -278,421,000USD | -273,852,000USD | -268,916,000USD |
| Accumulated Other Comprehensive Income | -63,000USD | -24,000USD | 1,000USD | -3,000USD | -11,000USD | — |
| Total Liab | — | 14,191,000USD | 4,310,000USD | 4,582,000USD | 4,469,000USD | 6,286,000USD |
| Other Current Liab | — | 9,733,000USD | 2,112,000USD | 2,255,000USD | 1,559,000USD | 75,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 3,000USD |
| Cash | — | 152,325,000USD | 8,668,000USD | 10,562,000USD | 12,557,000USD | 9,877,000USD |
| Cash And Short Term Investments | — | 202,793,000USD | 21,184,000USD | 25,041,000USD | 28,628,000USD | — |
| Net Debt | — | -151,286,000USD | -7,159,000USD | -8,541,000USD | -9,998,000USD | — |
| Short Long Term Debt Total | — | 1,039,000USD | 1,509,000USD | 2,021,000USD | 2,559,000USD | — |
| Short Term Investments | — | 50,468,000USD | 12,516,000USD | 14,479,000USD | 16,071,000USD | 24,454,000USD |
| Property Plant Equipment Gross | — | 1,563,000USD | 1,917,000USD | 2,296,000USD | 2,667,000USD | 3,015,000USD |
| Common Stock Shares Outstanding | — | 1,295,052shares | 1,260,772shares | 1,261,290shares | 1,260,867shares | 1,260,403shares |
| Non Current Assets Total | — | 1,149,000USD | 1,395,000USD | 1,804,000USD | 2,211,000USD | 2,591,000USD |
| Non Current Liabilities Total | — | 1,000USD | 59,000USD | 146,000USD | 596,000USD | 1,057,000USD |
| Non Currrent Assets Other | — | 167,000USD | 18,000USD | 18,000USD | 24,000USD | 24,000USD |
| Net Working Capital | — | 190,042,000USD | 17,256,000USD | 21,349,000USD | 25,699,000USD | 30,453,000USD |
| Unclassified Equity | — | 644,587,000USD | 301,728,000USD | 301,431,000USD | 301,177,000USD | 300,900,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | 4,793,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,057,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 22,902,000USD | 45,361,000USD | 74,374,000USD | 118,375,000USD |
| Other Current Assets | 323,000USD | 594,000USD | 1,493,000USD | 1,473,000USD |
| Total Liab | 4,310,000USD | 6,975,000USD | 9,479,000USD | 14,968,000USD |
| Total Stockholder Equity | 18,592,000USD | 38,386,000USD | 64,895,000USD | 103,407,000USD |
| Other Current Liab | 2,112,000USD | 2,886,000USD | 1,510,000USD | 2,462,000USD |
| Capital Stock | 0USD | 0USD | 3,000USD | 3,000USD |
| Retained Earnings | -283,137,000USD | -262,052,000USD | -231,895,000USD | -197,794,000USD |
| Cash | 8,668,000USD | 9,994,000USD | 13,011,000USD | 17,795,000USD |
| Cash And Short Term Investments | 21,184,000USD | 41,335,000USD | 65,757,000USD | 107,116,000USD |
| Total Current Assets | 21,507,000USD | 41,929,000USD | 67,250,000USD | 108,589,000USD |
| Total Current Liabilities | 4,251,000USD | 5,448,000USD | 5,643,000USD | 9,066,000USD |
| Net Debt | -7,159,000USD | -6,149,000USD | -6,803,000USD | -9,762,000USD |
| Short Term Debt | 1,450,000USD | 2,318,000USD | 2,439,000USD | 2,131,000USD |
| Short Long Term Debt Total | 1,509,000USD | 3,845,000USD | 6,208,000USD | 8,033,000USD |
| Short Term Investments | 12,516,000USD | 31,341,000USD | 52,746,000USD | 89,321,000USD |
| Accounts Payable | 689,000USD | 244,000USD | 1,694,000USD | 4,473,000USD |
| Property Plant Equipment Net | 1,377,000USD | 3,384,000USD | 7,038,000USD | 9,724,000USD |
| Property Plant Equipment Gross | 1,917,000USD | 4,880,000USD | 8,765,000USD | 11,166,000USD |
| Accumulated Other Comprehensive Income | 1,000USD | -13,000USD | -209,000USD | -1,004,000USD |
| Common Stock Shares Outstanding | 1,260,772shares | 25,117,000shares | 27,952,857shares | 30,703,295shares |
| Non Current Assets Total | 1,395,000USD | 3,432,000USD | 7,124,000USD | 9,787,000USD |
| Non Current Liabilities Total | 59,000USD | 1,527,000USD | 3,836,000USD | 5,902,000USD |
| Non Currrent Assets Other | 18,000USD | 48,000USD | 86,000USD | 63,000USD |
| Net Working Capital | 17,256,000USD | 36,481,000USD | 61,607,000USD | 99,523,000USD |
| Unclassified Equity | 301,728,000USD | 300,448,000USD | 296,993,000USD | 302,199,000USD |
| Common Stock | — | 3,000USD | 3,000USD | 3,000USD |
| Unclassified Non Current Liabilities | — | 1,527,000USD | 3,769,000USD | 5,902,000USD |
| Non Current Liabilities Other | — | — | 67,000USD | — |
| Other Assets | — | — | — | -1,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD |
|---|---|---|---|---|---|
| Net Income | -170,236,000USD | -4,717,000USD | -4,568,000USD | -4,936,000USD | -6,864,000USD |
| Depreciation | 30,000USD | 34,000USD | 34,000USD | 37,000USD | 34,000USD |
| Stock Based Compensation | 12,898,000USD | 295,000USD | 254,000USD | 264,000USD | 461,000USD |
| Other Non Cash Items | 133,255,000USD | 238,000USD | 225,000USD | 214,000USD | 411,000USD |
| Change In Working Capital | 13,320,000USD | 286,000USD | 469,000USD | -1,488,000USD | -859,000USD |
| Total Cash From Operating Activities | -10,733,000USD | -3,864,000USD | -3,586,000USD | -5,909,000USD | -7,094,000USD |
| Capital Expenditures | -6,000USD | 0USD | 0USD | -16,000USD | 0USD |
| Free Cash Flow | -10,739,000USD | -3,864,000USD | -3,586,000USD | -5,925,000USD | -7,094,000USD |
| Investments | -37,894,000USD | 2,081,000USD | 1,743,000USD | 8,563,000USD | 7,151,000USD |
| Total Cashflows From Investing Activities | -31,436,000USD | 2,081,000USD | 1,743,000USD | 8,757,000USD | — |
| Net Borrowings | -62,000USD | -113,000USD | -152,000USD | -172,000USD | -211,000USD |
| Total Cash From Financing Activities | 185,826,000USD | -111,000USD | -152,000USD | -168,000USD | -214,000USD |
| Sale Purchase Of Stock | -15,145,000USD | 0USD | 0USD | -1,000USD | 0USD |
| Issuance Of Capital Stock | 200,000,000USD | — | — | — | 0USD |
| Change In Cash | 143,657,000USD | -1,894,000USD | -1,995,000USD | 2,680,000USD | -117,000USD |
| Begin Period Cash Flow | 8,668,000USD | 10,562,000USD | 12,557,000USD | 9,877,000USD | 9,994,000USD |
| End Period Cash Flow | 152,325,000USD | 8,668,000USD | 10,562,000USD | 12,557,000USD | 9,877,000USD |
| Other Cashflows From Financing Activities | -14,112,000USD | — | — | 141,000USD | — |
| Unclassified Investing Cash Flow | 6,464,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 215,145,000USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | -40,000USD | 40,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -21,085,000USD | -30,157,000USD | -34,101,000USD | -48,588,000USD |
| Depreciation | 139,000USD | 1,322,000USD | 1,351,000USD | 1,347,000USD |
| Stock Based Compensation | 1,274,000USD | 3,135,000USD | 4,454,000USD | 5,812,000USD |
| Other Non Cash Items | 811,000USD | 1,519,000USD | 603,000USD | 1,395,000USD |
| Change In Working Capital | -1,592,000USD | -489,000USD | -4,330,000USD | 1,008,000USD |
| Total Cash From Operating Activities | -20,453,000USD | -24,670,000USD | -32,023,000USD | -39,026,000USD |
| Capital Expenditures | -16,000USD | -146,000USD | -180,000USD | -321,000USD |
| Free Cash Flow | -20,469,000USD | -24,816,000USD | -32,203,000USD | -39,347,000USD |
| Investments | 19,538,000USD | 22,586,000USD | 38,426,000USD | 50,255,000USD |
| Total Cashflows From Investing Activities | 19,772,000USD | 22,440,000USD | 38,412,000USD | 49,949,000USD |
| Net Borrowings | -648,000USD | -811,000USD | -761,000USD | -629,000USD |
| Total Cash From Financing Activities | -645,000USD | -787,000USD | -11,173,000USD | -287,000USD |
| Sale Purchase Of Stock | -1,000USD | 0USD | -10,384,000USD | 0USD |
| Change In Cash | -1,326,000USD | -3,017,000USD | -4,784,000USD | 10,636,000USD |
| Begin Period Cash Flow | 9,994,000USD | 13,011,000USD | 17,795,000USD | 7,159,000USD |
| End Period Cash Flow | 8,668,000USD | 9,994,000USD | 13,011,000USD | 17,795,000USD |
| Other Cashflows From Financing Activities | -3,000USD | -10,000USD | -28,000USD | — |
| Issuance Of Capital Stock | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.